Veerhealth Care Ltd (NIYATILEAS) — FY26 Annual Report | 31 August 2026(2 announcements)

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Annual Report 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Annual General Meeting scheduled for September 23, 2026 via Video Conferencing.
🔄 What Changed
Revenue increased to ₹3248.45 Lakhs (from ₹1667.05 Lakhs), net profit rose to ₹54.40 Lakhs (from ₹39.14 Lakhs), and no dividend was recommended for 2025-26.
🔮 What's Next
The company plans to expand exports, grow Ayuveer brand, and utilize funds from fully convertible warrants for strategic growth.
💡 Investor Takeaway
The company shows strong revenue and profit growth but does not recommend dividends, focusing on reinvestment for expansion.

Veerhealth Care Limited's 2025-26 Annual Report shows revenue growth to [amount context mismatch] Lakhs from ₹1667.05 Lakhs, with net profit rising to ₹54.40 Lakhs from ₹39.14 Lakhs. The Board recommends no dividend for 2025-26. Key appointments include Mrs. Shruti A. Shah's reappointment as Director. The AGM is scheduled for September 23, 2026 via VC. The company raised funds through fully convertible warrants and plans to expand exports and Ayuveer brand growth. Material risks include raw material cost pressures, competition, and regulatory changes. The audit report is unqualified with no material weaknesses in internal controls.

2 Annual Report 🔴 High Importance Neutral 📄 PDF
📢 Key Event
34th AGM scheduled for 23 September 2026 via video conference.
💡 Investor Takeaway
Shareholders must update KYC and register email to receive dividends and access the Annual Report online.

Veerhealth Care Limited announced its 34th Annual General Meeting scheduled for 23 September 2026 via video conference, reminding shareholders to update KYC details, register email addresses, and dematerialize physical securities to continue receiving dividends and payments electronically from April 1, 2024, with the full Annual Report available at https://veerhealthcare.net/annual-report/.

About Veerhealth Care Ltd (NIYATILEAS)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹98.65 Cr P/E: 64.9 ROE: 6.9% ROCE: 11.2%

View full NIYATILEAS stock details →

📡 Get AI alerts when NIYATILEAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NIYATILEAS — Free

📊 More NIYATILEAS filings

See all NIYATILEAS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NIYATILEAS files new disclosures

Track NIYATILEAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NIYATILEAS — Free

Free account · 2 AI queries/day